龙虎交战针法治疗缺血性脑卒中临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R743.3

基金项目:

浙江省医药卫生科研计划项目(2020KY479)


Clinical Study of Dragon-Tiger Contending Needling Method for Ischemic Stroke
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察龙虎交战针法治疗缺血性脑卒中的临床疗效及其对血清miR-431 和miR-1247 的影 响。方法:选取2020 年5 月—2022 年1 月就诊的缺血性脑卒中气虚血瘀证患者98 例为研究对象,随机分为 2 组各49 例。对照组给予脑心通胶囊,观察组在对照组治疗方案的基础上采用龙虎交战针刺法治疗,2 组均治 疗4 周。比较2 组美国国立卫生研究院卒中量表(NIHSS) 评分、Fugal-Meyer 运动功能评估量表(FMA) 评 分、Barthel 指数(BI)评分及临床疗效。比较2 组炎症指标[白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)、肿 瘤坏死因子-α(TNF-α)]、免疫功能(T 淋巴细胞亚群CD3+、CD4+、CD8+)、血清miR-431、血清miR-1247 等指标。采用Pearson 相关分析miR-431、miR-1247 与炎症、免疫指标的关系,多因素Logistic 回归和ROC 曲线分析miR-431、miR-1247 对卒中复发的影响。结果:治疗后,2 组NIHSS 评分均低于治疗前,FMA 评 分、BI 评分均高于治疗前,且观察组NIHSS 评分低于对照组,FMA、BI 评分高于对照组,差异均有统计学意 义(P<0.05);治疗后,2 组IL-1β、IL-6、TNF-α 均低于治疗前,且观察组IL-1β、IL-6、TNF-α 水平均低 于对照组,差异均有统计学意义(P<0.05);2 组CD3+、CD4+、CD8+ T 细胞水平均高于治疗前,且观察组 CD3+、CD4+、CD8+T 细胞水平均高于对照组,差异均有统计学意义(P<0.05);治疗后,2 组miR-431、miR- 1247 水平均低于治疗前,且观察组miR-431、miR-1247 水平均低于对照组,差异均有统计学意义(P< 0.05)。血清miR-431、miR-1247 水平与CD3+、CD4+、CD8+ T 淋巴细胞水平呈负相关(P<0.05),与IL-1β、 IL-6、TNF-α 水平呈正相关(P<0.05)。miR-431、miR-1247 是脑卒中复发的独立危险因素(P<0.05),二者 联合预测脑卒中复发的AUC 为0.942。结论:龙虎交战针法能改善缺血性脑卒中气虚血瘀证患者运动功能和生 活质量,减轻炎症反应,提高免疫功能,降低血清miR-431、miR-1247 水平,上述miRNA 是卒中复发的独立 危险因素,具有较高的临床预测价值。

    Abstract:

    Abstract: Objective: To observe the clinical effect of dragon- tiger contending needling method for ischemic stroke and its effects on miR- 431 and miR- 1247 in serum. Methods: A total of 98 cases of patients who had ischemic stroke with qi deficiency and blood stasis syndrome and treated from May 2020 to January 2022 were selected as study objects and randomly divided into two groups,with 49 cases in each group. Clinical effects and the scores of National Institute of Health stroke scale (NIHSS),Fugal- Meyer Assessment Scale (FMA), and Barthel Index (BI) were compared between the two groups. Inflammatory indicators [interleukin- 1β (IL- 1β),interleukin 6 (IL- 6),tumor necrosis factor- α (TNF- α)], immune function (T-lymphocytes:CD3+,CD4+,CD8+ ),serum miR-431,serum miR-1247 and other indicators were compared between the two groups. Pearson correlation analysis was used to analyze the relationship between miR-431 and miR-1247 and inflammatory and immune indicators. Multifactor logistic regression and ROC curve were used to analyze the impact of miR- 431 and miR- 1247 on stroke recurrence. Results: After treatment, NIHSS scores in the two groups were lower than those before treatment,and the scores of FMA and BI were higher than those before treatment;NIHSS score in the observation group was lower than that in the control group, and the scores of FMA and BI in the observation group were higher than those in the control group,differences being significant (P<0.05). After treatment,levels of IL-1β,IL-6,and TNF-α in the two groups were lower than those before treatment, and the three levels in the observation group were lower than those in the control group,differences being significant (P<0.05);the levels of T- lymphocyte including CD3 +,CD4 +,CD8 + in the two groups were higher than those before treatment,and the three levels in the observation group were higher than those in the control group,differences being significant (P<0.05). After treatment,the levels of miR-431 and miR- 1247 in the two groups were lower than those before treatment, and the two levels in the observation group were lower than those in the control group, differences being significant (P<0.05). There was a negative correlation between the levels of serum miR- 431 and miR-1247 and the levels of CD3+,CD4+, and CD8 + T lymphocytes (P<0.01),and a positive correlation between the levels of serum miR- 431 and miR- 1247 and the levels of IL- 1 β, IL- 6, and TNF- α (P<0.01). MiR- 431 and miR- 1247 were independent risk factors for stroke recurrence (P<0.05),and the AUC was 0.942 for stroke recurrence with a combined forecast of miR- 431 and miR- 1247. Conclusion: For patients with ischemic stroke with qi deficiency and blood stasis syndrome,dragon-tiger contending needling method can improve their motor function,quality of life,and immune function and reduce inflammatory reactions and the levels of miR- 431 and miR-1247 in serum. The above two miRNAs are independent risk factors for stroke recurrence and have high clinical predictive values.

    参考文献
    相似文献
    引证文献
引用本文

许嘉隆,应晓明,赵钰琦,郭少卿.龙虎交战针法治疗缺血性脑卒中临床研究[J].新中医,2023,55(20):125-131

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-10-27
  • 出版日期: